skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I had purchased CXR, aware of some inherent risk, but comforted to some degree by an element of reassurance from analysts I respect - including those at 5i - and held on to cxr, to my huge detriment having lost a significant amount of $ on Friday. This is not a question, but rather an expression of gratitude in the midst of CXR's debacle for the much-appreciated alert you provided us; I sold on Friday to redeploy the funds into something I hope will turn out to be more generous. Thanks again. It's time to move on. Regards.
Read Answer Asked by francesco on August 14, 2016
Q: I know that you are removing from the Growth Portfolio today but what should an investor with real money on the line do that's down 70%. This was a 7% position in my portfolio. Should I just eat the loss and move on or hold for 5 years to see if I get my money back (or at least some of it)? I don't need access to the capital for at least another 15 years.
Read Answer Asked by Rob on August 12, 2016
Q: For those of us who bought CXR above 60$/share, selling here won't recover much cash and so I wonder, is there a point selling? What if like WIN or PHM, we sell near the bottom? The guidance is reduced, but some of this was out of their control (currency due to Brexit). If there was a fraud, yes, I agree, but EPS is 3.2% down and revenue revised by 18%. Not good, but they aren't the only ones with troubles (Brystol-Meyers and Gildan). At least they are doing something about it: laying off the CFO and cutting the (small) dividend.
Read Answer Asked by Matt on August 12, 2016
Q: Trying to think of away to avoid two mistake made recently, or at least increase odds of avoiding in future.

PHM purchased and then up over 100% in few weeks/months, then down to minus 30%-50% range few weeks/months later.

CXR purchased and then up over 70% in few weeks, then down to minus 30%-50% range in a few more months.

Gross losses manageable as portfolio weighting was responsible.

PHM I guess fundamentals did not justify the increase and was popular stock at time is best thought I can think of and maybe a soft sell signal?

CXR seemed to go up on short covering, then down dramatically, then slightly back up on takeover rumours. No idea what to have done differently on this one. Feel like the CEO and CFO just dishonest on it.

Ideas? Lessons?
Read Answer Asked by John on August 12, 2016
Q: A year ago, Knight signed a deal to distribute 3 of Advaxis's products in Canada and bought about 400,000 shares at $13.91, a premium at the time from the Advaxis treasury. The shares tanked to $5, recovered to $8 and have jumped %6 to $14 in the past 3 days on the announcement that Amgen bought worldwide rights to another Advaxis drug and gave them $40 Million. This will help Knight as the shares appreciate but will it hurt their deal on the other 3 drugs they represent as Advaxis may concentrate on the behemoth deal with a super-large pharma co. and neglect their other products.
Knight's share price has help up well during the healthcare decline. Do you think they will one day do a big deal or continue to drip out their $600M in miniscule does? I am sure this company will be a blockbuster some day, but I may not live long enough to see it!
Thanks.
Read Answer Asked by Steven on August 05, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!